1060 / 1851
Take Home Message
for Oligometastatic NSCLC
A
combination
of chemo or immunotherapy + local therapies could
probably
improve patients outcome
in this setting, at least in selected subgroups
Phase III trials are warranted
to confirm the effectiveness of a multimodality
approach in this setting.
In the meantime…
Unity Makes Strength…!